Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.
| Discipline | Cardiology, cardiovascular biology |
|---|---|
| Language | English |
| Edited by | Alan Daugherty |
| Publication details | |
Former name(s) | Arteriosclerosis; Arteriosclerosis and Thrombosis |
| History | 1981–present |
| Publisher | Lippincott Williams & Wilkins on behalf of the American Heart Association (United States) |
| Frequency | Monthly |
Open access | Hybrid |
| 10.514 (2021) | |
| Standard abbreviations | |
| ISO 4 | Arterioscler. Thromb. Vasc. Biol. |
| Indexing | |
| CODEN | ATVBFA |
| ISSN | 1079-5642 (print) 1524-4636 (web) |
| LCCN | 95644718 |
| OCLC no. | 31441121 |
| Links | |
The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).
According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311, ranking it 8th in the category "Hematology" and 5th in the category "Peripheral Vascular Disease". Alan Daugherty has been the editor-in-chief since 2012.